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non–acid-loaded rats. Finally, the osteoblast surface was lessChronic metabolic acidosis in azotemic rats on a high-phosphate
in the N 1 Ac group than in the other groups. However, indiet halts the progression of renal disease.
the acid-loaded azotemic group (RF 1 Ac), the osteoblastBackground. Hyperphosphatemia and metabolic acidosis
surface was not reduced.are general features of advanced chronic renal failure (RF),
Conclusions. The presence of chronic metabolic acidosis inand each may affect mineral metabolism. The goal of the pres-
5/6 nephrectomized rats on a high-phosphate diet (1) protectedent study was to evaluate the effect of chronic metabolic acido-
against the progression of RF, (2) enhanced the renal clearancesis on the development of hyperparathyroidism and bone dis-
of phosphate, (3) resulted in a lesser degree of hyperparathy-ease in normal and azotemic rats on a high-phosphate diet.
roidism, and (4) did not reduce the osteoblast surface. TheOur assumption that the two groups of azotemic rats (acid-
combination of metabolic acidosis and phosphate loading mayloaded vs. non–acid-loaded) would have the same degree of
renal failure at the end of the study proved to be incorrect. protect against the progression of RF and possibly bone disease
Methods. Four groups of rats receiving a high-phosphate because the harmful effects of acidosis and phosphate loading
(1.2%), normal-calcium (0.6%) diet for 30 days were studied: may be counterbalanced.
(1) normal (N); (2) normal 1 acid (N 1 Ac) in which 1.5%
ammonium chloride (NH4Cl) was added to the drinking water
to induce acidosis; (3) RF, 5/6 nephrectomized rats; and (4)
Hyperphosphatemia and metabolic acidosis are gen-RF 1 acid (RF 1 Ac) in which 0.75% NH4Cl was added to
eral features of advanced chronic renal failure [1, 2].the drinking water of 5/6 nephrectomized rats to induce acidosis.
Results. At sacrifice, the arterial pH and serum bicarbonate Both hyperphosphatemia and metabolic acidosis may
were lowest in the RF 1 Ac group and were intermediate in have diverse effects on calcium metabolism, calcium reg-
the N 1 Ac group. Serum creatinine (0.76 6 0.08 vs. 1.15 6
ulating hormones, and bone (Table 1). In studies in azo-0.08 mg/dL), blood urea nitrogen (52 6 8 vs. 86 6 13 mg/dL),
temic animals, a high-phosphate diet has been shown toparathyroid hormone (PTH; 180 6 50 vs. 484 6 51 pg/mL),
and serum phosphate (7.46 6 0.60 vs. 12.87 6 1.4 mg/dL) values induce marked hyperphosphatemia and hypocalcemia
were less (P , 0.05), and serum calcium (9.00 6 0.28 vs. 7.75 6 [3, 4], markedly exacerbate the magnitude of secondary
0.28 mg/dL) values were greater (P , 0.05) in the RF 1 Ac hyperparathyroidism [3, 4], induce the bone disease of
group than in the RF group. The fractional excretion of phos-
hyperparathyroidism known as osteitis fibrosa [5], fur-phate (FEP) was greater (P , 0.05) in the two azotemic groups
ther reduce serum calcitriol levels [4], and to acceleratethan in the two nonazotemic groups. In the azotemic groups,
the FEP was similar even though PTH and serum phosphate the progression of renal failure [6].
values were less in the RF 1 Ac than in the RF group. NH4Cl- Acid loading in normal animals and humans increases
induced acidosis produced hypercalciuria in the N 1 Ac and urinary calcium excretion [7–9] and produces a phospha-
RF 1 Ac groups. When acid-loaded (N 1 Ac and RF 1 Ac) and
turia that is independent, at least in part, of parathyroidnon–acid-loaded (N and RF) rats were combined as separate
hormone (PTH) [8, 10–14]. Metabolic acidosis may alsogroups, serum phosphate and PTH values were less for a simi-
larly elevated serum creatinine value in acid-loaded than in affect calcium-regulating hormones. Although study re-
sults often have not been consistent, there has been a
suggestion that acidosis increases PTH values [15–17].
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Table 1. Potential mechanisms by which acidosis and phosphate excretion and in renal failure, its importance may in-
loading may affect the regulation of calcium
crease as ammonia production is compromised [39]. Inand phosphate and bone disease
normal humans and rats, an intravenous infusion of neu-
Metabolic acidosis tral phosphate has been shown to induce metabolic alka-1. Enhanced renal excretion of calcium and phosphate
losis and to increase titratable acidity markedly without2. Effect on regulatory hormones
a. PTH—probably increases increasing ammonia excretion [40, 41]. Conceptually,
b. Calcitriol—contradictory—decrease, no change, or increase metabolic acidosis could also function to retard phos-3. Skeletal response to PTH—contradictory
phate uptake by proximal tubule cells [11, 42] and en-4. Phosphate metabolism
a. Increase intracellular catabolism and release of phosphate hance citrate uptake by these same cells [43], both of
b. Increase release of phosphate from bone which may protect against phosphate-induced tubularc. Direct effect on renal phosphate excretion
damage, which occurs as calcium-phosphate deposition.5. Direct effect on bone
a. Physicochemical dissolution Moreover, phosphate loading has been shown to de-
b. Activation of osteoclasts crease urinary calcium excretion [41, 44–47] and the netc. Inhibition of osteoblasts and bone formation—shown primarily
movement of calcium from bone [44, 48, 49], and mayin vitro
6. Increase in renal citrate reabsorption also decrease osteoclastic bone resorption [50] and in
Phosphate loading certain conditions, even when serum phosphate is not1. Increase in urinary titratable acidity
low, enhance osteoid mineralization [36, 51]. In addition,2. Decrease in renal ammonia production
3. Decrease in urinary calcium excretion phosphate loading increases PTH levels, which may act
4. Decrease in net movement of calcium from bone to increase bone formation [52] and urinary calcium re-5. Possible enhanced osteoid mineralization in states of decreased
absorption. All of these effects of phosphate would bephosphate availability
6. Possible decrease in osteoclastic resorption opposite to those produced by acidosis.
7. Increase in serum PTH levels Our goal was to evaluate the effect of chronic meta-8. Decrease in serum calcitriol levels
bolic acidosis on the development of hyperparathyroid-
ism and bone disease in normal and azotemic rats receiv-
ing a high-phosphate diet. Our initial assumption was
that the magnitude of renal failure and hyperparathy-from those of acidosis. In addition to the enhanced bone
roidism would be similar in the two groups of azotemicrelease of phosphate caused by metabolic acidosis, stud-
rats, thus allowing a comparison of the effect of meta-ies in azotemic patients and animals have shown that
bolic acidosis on the bone disease. However, our assump-metabolic acidosis increases protein catabolism [22–27],
tion proved to be incorrect.which probably also increases the degree of hyperphos-
phatemia [23, 28].
Another critical issue is whether metabolic acidosis METHODS
directly affects the development of renal osteodystrophy Male Wistar rats weighing 180 to 200 g were used for
[29]. As shown in Table 1, acidosis has diverse effects the study. In two of the four study groups, renal failure
on bone. In in vitro studies, Bushinsky has shown that was surgically induced by arterial ligation of two of the
metabolic acidosis enhances osteoclast resorption and in- three hilar branches of the left main renal artery. This
hibits osteoblast function [30–32]. Studies in nonazotemic was followed one week later by a right nephrectomy.
rats have suggested that acid loading enhances bone re- In the two nonazotemic groups, sham operations were
sorption, but its effect on bone formation is less clear performed at the same time intervals. During surgical
[12, 33]. In the only study to evaluate the effect of acidosis procedures, rats were anesthetized with intraperitoneally
on bone disease in azotemic rats, bone formation was administered ketamine 7.5 mg/100 g (Ketaset; Fort Dodge
unaffected, but bone resorption was increased [34]. In Laboratories, Fort Dodge, IA, USA) and xylazine 0.5
studies in humans with chronic RF, severe metabolic aci- mg/100 g (AnaSed; Lloyd Laboratories, Shenandoah,
dosis has been associated with impaired mineralization IA, USA). Rats were housed in individual cages, given
and an increased incidence of osteomalacia [10, 35–37]. 14 g of food daily, and allowed free access to water. The
In the only study performed in dialysis patients, failure amount of food eaten did not differ among the groups
to correct acidosis did not impair mineralization, but because rats were removed from the study if they did
rather resulted in an increase in PTH levels that was not consistently consume greater than 90% of their diet.
associated with an increase in the osteoblast surface [38]. After the right nephrectomy or sham operation, the
While it might seem that the effects of phosphate re- four groups of rats were placed on a high phosphate diet
tention and acidosis are not interrelated, such a conclu- (1.2%) for 30 days. The diet also contained 0.6% calcium
sion may not be correct. As shown in Table 1, phosphate and 100 IU of vitamin D per 100 g of diet (ICN, Cleve-
loading may counteract certain effects of acidosis. Phos- land, OH, USA). The four groups were (1) normal (N,
N 5 10); (2) normal 1 acid (N 1 Ac, N 5 8) in whichphate is one of the two primary urinary buffers for acid
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Table 2. Arterial blood gases and weights at sacrifice
N N 1 Ac RF RF 1 Ac ANOVA
N 5 10 N 5 7 N 5 16 N 5 10 P value
pH 7.3060.02 7.2860.03 7.3260.01 7.2360.03a 50.03
pCO2 mm Hg 46.161.6 42.761.1 47.261.6 40.961.7a 50.04
HCO3 mEq/L 22.760.5 20.161.5 23.560.7b 17.561.2c ,0.001
Weight g 24665 25068 23168 24069 5NS
Abbreviations are: N, normal; N 1 Ac, normal 1 acid; RF, renal failure; RF 1 Ac, renal failure 1 acid. Data are mean 6 SE.
a P , 0.05 vs. N and RF groups
b P , 0.05 vs. N 1 Ac group
c P , 0.05 vs. other three groups
1.5% NH4Cl was added to the drinking water; (3) renal (ANOVA) followed by the Duncan test for multiple
failure (RF, N 5 16); and (4) renal failure 1 acid (RF 1 comparisons. The association between two variables was
Ac, N 5 10) in which 0.75% NH4Cl was added to the assessed by Pearson’s linear correlation. A comparison
drinking water. In the RF 1 Ac group, drinking water of the slopes of two regression lines was based on the
containing 1.5 and 1.0% NH4Cl was tested during a formula t 5 (b1 2 b2)/(Sb1 2 Sb2), in which b equals the
seven-day pilot study in a small number of rats but was slope and Sb equals the standard error of the slope [54].
poorly tolerated because of severe acidosis. Two days A P value of less than 0.05 was considered significant.
before sacrifice, rats were placed in a metabolic cage, Results are expressed as the mean 6 SE.
and a 24-hour urine was collected during the second day.
On day 30 after an overnight fast, rats were anesthetized,
RESULTSand the abdomen was opened. After exposure of the
Arterial blood gases and weight at sacrificeabdominal aorta, blood was obtained from the aorta for
blood gas analysis. Rats were then sacrificed by exsangui- The weight at sacrifice was not different among the
nation from the abdominal aorta. four groups (Table 2). The arterial pH was lower in the
After sacrifice the ilium was detached from the skele- RF 1 Ac group than in the N and RF groups. Serum
ton and processed undecalcified as previously described bicarbonate was lower in the RF 1 Ac group than in
[53]. Five micrometer Goldner-stained sections of can- the other three groups and lower in the N 1 Ac than
cellous bone were examined for cellular detail, osteoid, in the RF group. The mild respiratory acidosis present
and mineralized bone. The quantitation of the sample was in all the groups was most likely caused by the anesthetic
performed at a magnification 3400 with a Merz-Schenk xylazine, which can decrease respiratory muscle function.
eyepiece reticle, and at least 100 fields were analyzed.
The assessment of the bone was performed by one of the Blood chemistries and creatinine clearance
authors (A.J.F.) without the knowledge of the different
The most remarkable biochemical finding was thatgroups.
renal function, as determined by the serum creatinine,Serum calcium and phosphate and blood urea nitrogen
BUN, and creatinine clearance, was better in the acid-(BUN) were measured with specific kits (Sigma, St. Louis,
loaded, RF group (RF 1 Ac) than in the nonacid-loaded,MO, USA). Serum creatinine was measured with a creat-
RF group (RF; Table 3). Furthermore, serum calciuminine analyzer (Beckman, Fullerton, CA, USA). Mea-
was greater and both serum phosphate and PTH valuessurements performed on the 24-hour urine collection
were less in the RF 1 Ac than in the RF group. Nowere calcium and phosphate (Sigma) and creatinine
biochemical differences were present between the two(Beckman). Intact PTH was measured with an immuno-
nonazotemic groups (N and N 1 Ac). While in the RF 1radiometric assay specific for the rat (Nichols, San Juan
Ac group, parameters of renal function were intermedi-Capistrano, CA, USA). Serum calcitriol was measured
ate between the two nonazotemic groups (N and N 1with a radioreceptor assay by Nichols Institute; because
Ac) and the RF group, serum calcium and phosphateof the large aliquot of serum needed for measurement,
values were not different from the N and N 1 Ac groups.serum calcitriol could not be measured in all rats. Arte-
Serum calcitriol values were not different among therial pH, pO2, pCO2, and bicarbonate were measured with
four groups.a blood gas analyzer (Instrumentation Laboratories,
A direct correlation was present between serum creati-Lexington, MA, USA).
nine and BUN (r 5 0.86, P , 0.001), and an inverse
Statistics correlation was present between serum creatinine and
creatinine clearance (r 5 20.88, P , 0.001). InverseComparisons of the serum and urinary data among the
four groups were assessed by one-way analysis of variance correlations were also present between serum calcium
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Table 3. Serum chemistries and creatinine clearance
Serum N N 1 Ac RF RF 1 Ac ANOVA
Calcium mg/dL 9.1660.14 9.1760.13 7.7560.28a 9.0060.28 ,0.001
Phosphate mg/dL 6.9760.35 7.0860.62 12.8761.4a 7.4660.60 ,0.001
Creatinine mg/dL 0.4260.02 0.4160.03 1.1560.08a 0.7660.08b ,0.001
BUN mg/dL 3262 3262 86613a 5268 ,0.001
PTH pg/mL 76612 72618 484651a 180650 ,0.001
Calcitriol pg/mLc 144622 15169 126618 157627 NS
Creatinine clearanced mL/min 1.4660.08 1.4160.12 0.4860.09a 1.0160.14b ,0.001
Definitions of groups are in Table 2. Value given for ANOVA is the P value. Except for serum calcitriol and the creatinine clearance, the number of rats in each
group is the same as for Table 2. Data are mean 6 SE.
a P , 0.05 vs. other three groups
b P , 0.05 vs. N and N 1 Ac groups
c N values for serum calcitriol are: N (N 5 10), N 1 Ac (N 5 4), RF (N 5 13), and RF 1 Ac (N 5 8)
d N values for creatinine clearance are: N (N 5 6); N 1 Ac (N 5 7), RF (N 5 8), and RF 1 Ac (N 5 9)
Conversion to SI units:
1. To convert to mmol/L, multiply serum calcium (mg/dL) by 0.2495, phosphate (mg/dL) by 0.3229, and BUN (mg/dL) by 0.357
2. To convert to mmol/L, multiply serum creatinine (mg/dL) by 88.4
3. To convert to pmol/L, multiply PTH (pg/mL) by 0.106 and calcitriol (pg/mL) by 2.4
Fig. 1. Correlation between serum phosphate and serum creatinine. Fig. 2. Correlation between serum parathyroid hormone (PTH) and
Shown is the correlation between serum phosphate and serum creatinine serum creatinine. Shown is the correlation between serum PTH and
for the entire group and also for the two acid-loaded groups [(h) normal serum creatinine for the entire group and also for the two acid-loaded
(N) 1 acid (Ac) and (s renal failure (RF) 1 Ac)] and for the two groups [(h) N 1 Ac and (s) RF 1 Ac] and for the two non–acid-
non–acid-loaded groups [( ) N and ( ) RF]. Regression lines are shown loaded groups [( ) N and ( ) RF]. Regression lines are shown for the
for the correlation in the acid-loaded groups (dashed line) and in the correlation in the acid-loaded groups (dashed line) and in the non–acid-
non–acid-loaded groups (solid line). loaded groups (solid line).
and both serum phosphate (r 5 20.66, P , 0.001) and less (P , 0.001) in the acid-loaded group so that for a
serum PTH (r 5 20.65, P , 0.001). similar serum creatinine in RF, the serum PTH was less
Shown in Figure 1 is the significant correlation be- in the acid-loaded rats. A significant correlation was also
tween serum creatinine and serum phosphate (r 5 0.87, present between serum PTH and phosphate (r 5 0.77,
P , 0.001). To evaluate the effect of acidosis and to P , 0.001; data not shown).
have a range of values, acid-loaded (N 1 Ac and RF 1 An inverse correlation was present between serum
Ac) and non–acid-loaded (N and RF) groups were com- calcitriol and serum creatinine (r 5 20.40, P 5 0.02;
bined. As shown in Figure 1, significant correlations were Fig. 3). When only the azotemic rats (RF and RF 1 Ac)
present for both groups. In addition, the slope of the were included, the correlation between serum calcitriol
regression line was less (P , 0.001) in the acid-loaded and serum creatinine increased to r 5 20.64, P 5 0.002.
group. Thus, for a similar serum creatinine value in renal
Urine chemistries and volumefailure, the serum phosphate was less in acid-loaded rats.
As shown in Figure 2, the correlation between serum As shown in Table 4, urine volume was greater in the
two azotemic groups and the N 1 Ac group than in thecreatinine and PTH was significant (r 5 0.82, P , 0.001).
When the groups were separated into acid-loaded and N group. Urinary calcium excretion was greater in the N 1
Ac group than in the other three groups and intermediatenon–acid-loaded, significant correlations were present
for both groups. The slope of the regression line was in the RF 1 Ac group. The fractional excretion of cal-
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compare directly the effect of chronic metabolic acidosis
on the bone disease as well as biochemical changes. How-
ever, the acid-loaded, azotemic rats did not develop the
same degree of RF as the non–acid-loaded azotemic rats.
In addition to suggesting that metabolic acidosis has a
renoprotective effect in phosphate-loaded 5/6 nephrecto-
mized rats, our study results also suggest that acidosis
independently enhanced the renal clearance of phos-
phate. The increased renal phosphate clearance resulted
in a lower serum phosphate value, which likely contrib-
uted to the higher serum calcium level. Both the lower
serum phosphate and the higher serum calcium would
Fig. 3. Correlation between serum calcitriol and serum creatinine. function to moderate the development of secondary hy-
Shown is the inverse correlation between serum calcitriol and serum perparathyroidism.
creatinine (r 5 20.40, P 5 0.02). When this comparison was performed
only in the azotemic rats [( ) RF and (s) RF 1 Ac], the correlation
Acidosis, renal function, and serum chemistriesbetween serum calcitriol and creatinine increased to r 5 20.64, P 5
0.002 (regression is shown as a solid line). Symbols are: ( ) N; (h) Perhaps the most surprising feature of the study was
N 1 Ac.
that NH4Cl-induced metabolic acidosis slowed the pro-
gression of renal disease in phosphate-loaded, 5/6 ne-
phrectomized rats. In terms of renal failure, our results
in the acid-loaded, azotemic rats seem to resemble thosecium was less in the N group than in the other three
in studies in which dietary phosphate restriction wasgroups. Urinary creatinine and phosphate excretion was
shown to slow the progression of renal failure in 5/6similar among the four groups. However, the fractional
nephrectomized rats [6, 55, 56]. In previous studies inexcretion of phosphate (FEP) was greater in the RF and
normal animals and humans, metabolic acidosis has beenthe RF 1 Ac groups than in the N and N 1 Ac groups.
shown to enhance the renal clearance of phosphate [8,While the FEP was similar in the RF 1 Ac and the RF
11–14] independent of PTH [12, 14].groups, it was observed at much lower serum phosphate
Our results seem to contradict those of other studiesand PTH values in the RF 1 Ac group (Fig. 4).
in which it has been suggested that metabolic acidosis
Bone histomorphometry contributes to the progression of renal failure in azotemic
rats [57–59]. In those studies, the accelerated progressionAs shown in Table 5, the osteoblast and osteoid sur-
of renal failure has been primarily attributed to the in-faces as a percentage of the trabecular bone surface were
creased ammonia production needed to buffer the acidgreater in the RF than in the other three groups. The
load [57–59]. It has been suggested that in renal failure,osteoblast surface was also less in the N 1 Ac than in
the high ammonia level in renal venous blood, possiblythe N group. The osteoclast surface and the eroded sur-
because of the increased ammonia production per neph-face were greater in the RF than in the two nonazotemic
ron [60], activates the alternate complement pathwaygroups (N and N 1 Ac). Osteoid volume was greater in
by amidation resulting in tubulointerstitial tissue injurythe RF and tended to be less in the N 1 Ac than in the
[57, 58]. However, as has been shown in previous studiesN group. Bone volume was not different among the four
in normal animals and humans, phosphate loading in thegroups.
present study may have functioned to increase urinaryShown in Figure 5 is the significant correlation be-
titratable acidity and thus preclude any increase in am-tween PTH and the osteoblast surface (r 5 0.84, P ,
monia production [40, 41].0.001). When the rats were separated into acid-loaded
Many years ago, Holliday et al showed that an oral(N 1 Ac and RF 1 Ac) and non–acid-loaded (N and
phosphate load induces renal tubule damage in rats inRF), a significant correlation was present for both groups,
which metabolic alkalosis had been induced with a chlo-and the slopes of the two regression lines were not differ-
ride-depleted diet [61]. Subsequently, Levine et al showedent. The correlation between PTH and the osteoclast
that in rats in which metabolic alkalosis was induced bysurface for the four groups combined was also significant
chloride depletion, a high-phosphate diet induced severe(r 5 0.57, P 5 0.003; data not shown).
nephrocalcinosis, which did not develop in the absence
of metabolic alkalosis [62]. Studies in the rat by Mercier
DISCUSSION et al [63] and Houillier et al [40] have shown that pro-
Our expectation was that a similar degree of RF would longed phosphate loading enhances phosphate delivery
be present in the two azotemic groups, and as a result, to the distal nephron, which in turn stimulates renal acid
secretion provided that PTH is present. Previous studiesit would be possible in these phosphate-loaded rats to
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Table 4. Urinary data
N N 1 Ac RF RF 1 Ac ANOVA
Urinary N 5 6 N 5 7 N 5 8 N 5 9 P value
Volume mL/24 hours 10.161.7a 20.361.6 28.263.9 25.161.8 ,0.001
Calcium mg/24 hours 0.2460.03 2.7260.99a 0.4160.08 0.9360.08 ,0.01
Fractional excretion of calcium % 0.1360.03a 1.2560.43 1.2460.44 0.8160.12 ,0.01c
Creatinine mg/24 hours 8.4260.41 8.9361.09 7.9760.94 10.1560.63 5NS
Phosphate mg/24 hours 92.2613.6 119.4616.9 94.668.6 116.866.0 5NS
Fractional excretion of phosphate % 6068 7669 11466b 11866b ,0.001
Definitions of the groups are in Table 2.
a P , 0.05 vs. other three groups
b P , 0.05 vs. N and N 1 Ac groups
c The nonparametric Kruskal-Wallis test was used because of the unequal distribution of the data. Data are mean 6 SE.
Conversion to SI units: To convert to mmol/24 hours, multiply urinary calcium (mg/24 hours) by 0.02495, creatinine (mg/24 hours) by 8.840, and phosphate (mg/24 hours)
by 0.03229.
minimal amounts of interstitial bicarbonate are gener-
ated at the basolateral membrane of the collecting duct
because other than bicarbonate, the only luminal H1
acceptors are small quantities of phosphate and ammo-
nia [66]. However, Halperin has also suggested that if a
large quantity of a luminal hydrogen ion acceptor were
to be available, such as phosphate in the present study,
considerable amounts of bicarbonate would be gener-
ated, resulting in alkalinization of the medullary intersti-
tium and enhancing the potential for calcium deposition
and nephrocalcinosis [66]. Thus, the protective effect of
acidosis on renal function in our 5/6 nephrectomized rats
could be because the presence of acidosis minimized
the potential for calcium deposition in the medullary
interstitium.
In the two azotemic groups (RF and RF 1 Ac), distinct
differences in serum creatinine, BUN, calcium, phosphate,
PTH, and creatinine clearance were present. Because
renal function was different in the two 5/6 nephrecto-
mized groups, it is difficult to know whether the respec-
tive differences in serum chemistries were due to acidosis
or differences in renal function. When correlations were
performed between serum creatinine and both serum
phosphate and PTH, it became possible to consider cer-
tain conclusions in the two azotemic groups. When serum
creatinine and serum phosphate were compared, the cor-
relations were significant in both the renal failure and
the RF 1 Ac groups, but the slopes of the regression
lines were different. Thus, for similarly increased serumFig. 4. Fractional excretion of phosphate (FEP). (A) Shown is the frac-
tional excretion for phosphate for the serum phosphate concentration creatinine values, serum phosphate was less in the RF 1
in each of the four groups. In each group, the mean value and standard
Ac group, suggesting an enhanced renal clearance oferror for the FEP and the serum phosphate are shown. (B) Shown is
the fractional excretion for phosphate for the serum PTH concentration phosphate for a similar degree of renal failure. Thus,
in each of the four groups. In each group, the mean value and standard our data suggest that for retarding the progression of
error for the FEP and the serum PTH are shown. renal failure, lowering the serum phosphate concentra-
tion by means of decreasing the renal set point for phos-
phate reabsorption may be as effective as reducing the
serum phosphate by dietary intake.have shown that phosphate-induced renal damage and
While the interaction between chronic metabolic aci-nephrocalcinosis initially occur in the outer zone of the
dosis and phosphate has been the primary focus of thismedulla [6, 64, 65]. Halperin has developed a hypothesis
that suggests that despite the presence of H1-ATPase, study, chronic metabolic acidosis may have other effects
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Table 5. Bone histomorphometric data
N N 1 Ac RF RF 1 Ac ANOVA
N 5 6 N 5 5 N 5 9 N 5 7 P value
Osteoblast surface (Ob.S/BS, %) 15.261.8 6.763.6a 30.862.3a 16.063.0 ,0.001
Osteoblast surface (Ob.S/OS, %) 91.163.0 87.766.0 97.161.2 87.667.2 5NS
Osteoid surface (OS/BS, %) 17.062.4 7.663.0a 31.862.3a 18.663.6 ,0.001
Osteoclast surface (Oc.S/BS, %) 5.860.7 5.861.7 12.061.7b 8.761.8 0.03
Osteoclast number/mm2 (N.Oc./T.A.) 1.360.3 1.460.5 2.660.5 1.660.4 5NS
Eroded surface (ES/BS, %) 7.660.8 8.462.1 20.262.6b 14.462.6 ,0.01
Osteoid volume (OV/BV, %) 2.560.4 0.660.1 5.460.7a 2.460.6 ,0.001
Bone volume (BV/TV, %) 7.961.3 8.361.2 9.460.7 6.060.6 5NS
Definitions of the groups are in Table 2. Data are mean 6 SE. The definitions of the measured parameters are (1) osteoblast surface, the percent of trabecular
bone surface covered by osteoblasts (Ob.S/BS, %); (2) osteoblast surface, the percent of total osteoid surface covered by osteoblasts (Ob.S/OS, %); (3) osteoid
surface, the percent of trabecular bone surface covered by osteoid (OS/BS, %); (4) osteoclast surface, the percent of trabecular bone surface covered by osteoclasts
(Oc.S/BS, %); (5) osteoclast number, the number of osteoclasts per square millimeter of cancellous bone (N.Oc./T.A.); (6) eroded surface, the percent of bone
surface covered by resorption cavities (ES/BS, %); (7) osteoid volume, the percent of trabecular bone volume occupied by osteoid (OV/BV, %); and (8) bone
volume, the percent of cancellous bone (tissue volume) occupied by trabecular bone (BV/TV, %).
aP , 0.05 vs. other three groups
bP , 0.05 vs. N and N 1 Ac
groups. In addition to the phosphaturic effects of acidosis
and renal failure in specific groups, phosphaturic factors
present in all four groups included prolonged dietary
phosphate loading and hyperparathyroidism. Even in the
nonazotemic groups, PTH values were generally 1.5 to
2 times greater than those reported in rats on a normal-
phosphate (0.6%) diet [70]. Thus, a combination of fac-
tors likely contributed to the enhanced renal clearance
of phosphate among the four groups.
The FEP exceeded 100% in the two azotemic groups.
While it is generally accepted that the net phosphate
excretion is the result of the glomerular filtration minus
Fig. 5. Correlation between the osteoblast surface and serum PTH. the tubular reabsorption, it should be noted that in sev-Shown is the correlation between the osteoblast surface and serum
eral studies performed in rats adapted to high-phosphatePTH for the entire group and also for the two acid-loaded groups [(h)
N 1 Ac and (s) RF 1 Ac] and for the two non–acid-loaded groups diets, the excretion of phosphate has been reported to
[( ) N and ( ) RF]. One rat in the N 1 Ac group is not plotted because exceed the filtered load [71, 72]. In the present study,a PTH value was not available. Regression lines are shown for the
only a morning serum phosphate value obtained after ancorrelation in the acid-loaded groups (dashed line) and in the non–acid-
loaded groups (solid line). overnight fast was available. It is likely that serum phos-
phate values during feeding were greater than the morning
fasting value in the azotemic groups [70]. If it were possible
to obtain several serum phosphate values during the 24-that could affect renal function. These include: (1) an
hour urine collection, the integrated value would likelyincrease in glucocorticoid levels [67], which may be an
be greater than the fasting morning value, and such aimportant mediator of the phosphaturic response [68];
result would lower the FEP in the azotemic groups.(2) an increase in renal potassium excretion and hypoka-
lemia, which are associated with intracellular acidosis
Acidosis and bone diseaseand increased ammonia production [7, 13, 69]; and (3)
In in vitro studies in bone, metabolic acidosis has beenpotential changes in blood volume and blood pressure
shown to stimulate osteoclastic resorption and inhibitbecause of increases in renal sodium excretion [7, 9, 13].
osteoblast function [30–32]. In our nonazotemic rats, os-How dietary phosphate loading interacts with these fac-
teoblast surface and osteoid volume were less in the N 1tors in our chronic metabolic acidosis model in azotemic
Ac than in the N group, suggesting that the presence ofrats remains to be determined.
metabolic acidosis might have affected the osteoblast.
Acidosis and the excretion of calcium and phosphate However, in azotemic rats with acidosis (RF 1 Ac),
osteoblasts seemed to respond to higher PTH levels de-As has been shown in previous studies of NH4Cl ad-
spite severe acidosis.ministration [7–9, 12, 13], urinary calcium excretion was
In the only previous study of acid loading in 5/6 ne-greater in the groups receiving NH4Cl. The FEP was
greater in the two azotemic than in the two nonazotemic phrectomized rats, the magnitude of renal failure and
Jara et al: Metabolic acidosis, phosphate, and RF1030
hyperparathyroidism was similar between the acid- tients with residual renal function, the presence of meta-
loaded and non–acid-loaded azotemic rats [34]. The rea- bolic acidosis may function to reduce the calcium-phos-
son that the rats in the study by Chan et al had similar phate product as a result of renal losses of calcium and
serum creatinine and PTH values may have been because phosphate. In the present study, the dietary phosphate
the rats were on a high-calcium (1.3%), moderate-phos- loading likely precluded any deficiency in phosphate and
phate (0.72%) diet, and the acid loading was not started may have also minimized urinary calcium losses. Thus,
until three weeks after the surgical induction of renal both of these effects may have contributed to the mainte-
failure. While data on the osteoblast surface were not nance of a normal calcium-phosphate product in the
given, the bone formation rate was not different between acidotic, azotemic rats, and thus may have minimized
the two azotemic groups. However, the osteoclast surface the bone effects of acidosis.
was greater in the acid-loaded than in the non–acid- The study by LeFebvre et al is the only one to evaluate
loaded azotemic group. As in our study, the results of directly how the correction of acidosis affected renal
the study by Chan et al also suggested that in azotemic osteodystrophy in the hemodialysis patient [38]. In the
rats, bone formation was not affected by acidosis [34]. group in which acidosis was not corrected, PTH values
There have been several small studies [10, 35, 37, 73] tended to increase. The authors suggested that the impe-
and one large study [36] that have tried to evaluate the tus for the increase in PTH in untreated acidosis was
effect of acidosis on bone disease in the predialysis pa- an increased release of phosphate from bone; acidosis-
tient. Most of these studies have suggested a role for induced protein catabolism could have been another
metabolic acidosis in the development of osteomalacia. source of phosphate release [23, 28]. Despite continued
The effect of metabolic acidosis on the mineralization acidosis in the untreated group, the bone formation rate
process could be a direct effect [30, 31, 73–75], in which not only did not decrease, but increased commensurate
the necessary alkaline milieu at the site of mineralization with the increase in PTH. Despite acidosis, renal losses
could be altered. The mineralization process could be of calcium and phosphate would not be expected in he-
directly pH and bicarbonate dependent [74, 75], and one modialysis patients. Thus, the enhanced endogenous
suggested possibility is that an alkaline pH is necessary phosphate loading in these hemodialysis patients may
to generate trivalent phosphate to initiate the mineraliza- have produced a situation similar to that in our azotemic,
tion process [73, 74]. Metabolic acidosis also appears to acidotic rats in which exogenous phosphate loading may
have multiple indirect effects that could inhibit mineral- have prevented or minimized any adverse effects on
ization and favor the development of osteomalacia. Ex- bone formation. While bone formation was not mea-
clusive of the conflicting data on PTH and calcitriol, these sured directly in our study, the normal osteoid volume
indirect effects include a possible decrease in gut absorp-
would suggest that the balance between osteoid deposi-
tion of calcium [10, 76] and increased urinary losses of
tion and bone mineralization was unchanged at a timecalcium and phosphate [7–14]. Thus, as suggested more
when the osteoblast surface did not decrease. In boththan 30 years ago by Stanbury and Lumb [77] and subse-
the hemodialysis patients and our azotemic rats, thequently by others [36, 51, 78], it is possible that the pres-
higher PTH levels may have played a central role inence of hypocalcemia, relative hypophosphatemia (de-
maintaining remodeling in the presence of acidosis.fined as a serum phosphate in the normal range in contrast
In summary, chronic metabolic acidosis in phosphate-to the hyperphosphatemia in azotemic patients without
loaded, azotemic rats (1) protected against the progressionosteomalacia), or a low-calcium phosphate product may
of renal failure, (2) enhanced renal phosphate clearance,inhibit bone mineralization in the azotemic patient, espe-
(3) resulted in a lesser degree of hyperparathyroidism,cially in the presence of a limited capacity to produce
and (4) did not reduce the osteoblast surface. In conclu-calcitriol. Indeed, in patients with vitamin D-dependent
sion, the combination of chronic metabolic acidosis andrickets type II, in whom the high circulating calcitriol is
phosphate loading may protect against the progressionineffective because of a defective vitamin D receptor, it
of renal failure and possibly bone disease, because thehas been shown that prolonged calcium infusions can nor-
harmful effects of acidosis and phosphate loading maymalize the mineralization of rachitic bone [79–81]. Simi-
be counterbalanced. Acidosis may protect against phos-larly, in vitamin D-deficient rats [82–84] and in vitamin D
phate loading by enhancing renal phosphate clearancereceptor-ablated mice [85], calcium supplementation suf-
and by reducing the propensity for renal calcium-phos-ficient to normalize the serum calcium has been shown
phate deposition. Phosphate loading may protect againstto correct the abnormal mineralization even in the ab-
acidosis by (1) increasing urinary buffering of acid, whichsence of vitamin D. Furthermore, phosphate supplemen-
may minimize or prevent an increase in ammonia pro-tation may also be important [83–85]. Thus, a similar
duction, (2) stimulating osteoid mineralization, (3) in-process may develop in renal failure in which relative
creasing PTH levels, and (4) probably reducing bonedeficits of calcium and phosphate may adversely affect
bone mineralization [36, 51, 77, 78], and at least in pa- loss of calcium.
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